[
    [
        {
            "time": "",
            "original_text": "医药行业2022年投资策略报告：政策扰动下分化加剧 战略性看好医药黄金赛道上的优质个股",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "政策扰动",
                    "分化加剧",
                    "黄金赛道",
                    "优质个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2022年投资策略报告：政策扰动下分化加剧 战略性看好医药黄金赛道上的优质个股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]